ArticleBiomolecules2023

A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort.

Luis Toro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.